MYC and neoplasm: Omomyc has been shown to have a potent anti-proliferative effect with sustained tumour regression with no detrimental effect on healthy tissue, thus for the first time, c-MYC inhibition can be considered as a feasible therapeutic anti-cancer strategy [110].